You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bioequivalence Clorazepate Tablets

Showing 1 - 25 of 5,148
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Cairo (Bravamax 200 mg (Modafinil), Vigil 200 mg (Modafinil))

Completed
  • Healthy
  • Bravamax 200 mg (Modafinil)
  • Vigil 200 mg (Modafinil)
  • Cairo, Egypt
    Genuine Research Center GRC
May 3, 2023

Bioequivalence Study Trial in Beijing (Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g, Calcium Hydroxybenzene

Recruiting
  • Bioequivalence Study
  • Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g
  • Calcium Hydroxybenzene Sulfonate Tablets（Doxium®) 250mg
  • Beijing, Beijing, China
    National Institue for Drug Clinical Trials
Mar 21, 2023

Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)

Recruiting
  • Healthy Adult Subjects
  • San Antonio, Texas
    ICON Early Phase Services
Oct 24, 2023

Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)

Not yet recruiting
  • Viral Infection COVID-19
  • Saint Petersburg,, Russian Federation
    Limited Liability Company "Research Center Eco-Safety"
Oct 23, 2023

Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)

Completed
  • Healthy
  • Test Empagliflozin And Linagliptin Tablets
  • Reference Empagliflozin And Linagliptin tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023

Healthy Trial in Cairo (Apipe (Aripiprazole10 mg), Abilify (Aripiprazole10 mg))

Completed
  • Healthy
  • Apipe (Aripiprazole10 mg)
  • Abilify (Aripiprazole10 mg)
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 27, 2023

Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)

Not yet recruiting
  • Healthy
  • Test (T) Bilastine
  • Reference (R) Bilastine
  • (no location specified)
Oct 19, 2023

Tumors Trial in Bengbu (The test olaparib tablet (T), The reference olaparib tablet (R))

Completed
  • Neoplasms
  • The test olaparib tablet (T)
  • The reference olaparib tablet (R)
  • Bengbu, Anhui, China
    The First Affiliated Hospital of Bengbu Medical College
May 15, 2023

Type 2 Diabetes Trial (hrx0701 tablets?Metformin HCl tablets?Retagliptin phosphate tablets, hrx0701 tablets)

Completed
  • Type 2 Diabetes Mellitus
  • hrx0701 tablets、Metformin hydrochloride tablets、Retagliptin phosphate tablets
  • hrx0701 tablets
  • Changsha, Hunan, China
    Xiangya Third Hospital
Dec 20, 2022

Psoriasis and Psoriatic Arthritis Trial in Ahmedabad (Apremilast 30 mg Tablets, Otezla 30 mg film-coated tablets)

Completed
  • Psoriasis and Psoriatic Arthritis
  • Apremilast 30 mg Tablets
  • Otezla 30 mg film-coated tablets
  • Ahmedabad, Gujarat, India
    Lambda Therapeutic Research Ltd.
Oct 18, 2023

Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated

Completed
  • Bioequivalence
  • Healthy Subjects
  • Efez 50 mg eplerenone film-coated tablets
  • INSPRA® 50 mg eplerenone film-coated tablets
  • Amman, Jordan
    ACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022

Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets

Not yet recruiting
  • Healthy
  • Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
  • Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
  • (no location specified)
Jul 26, 2023

Myeloma Multiple Trial in Chia (Dasatinib 100 MG)

Not yet recruiting
  • Myeloma Multiple
  • Dasatinib 100 MG
  • Chia, Cundinamarca, Colombia
    CAIMED
Jul 12, 2023

Healthy Trial in Qingdao (test apixaban tablets, reference apixaban tablets)

Completed
  • Healthy
  • test apixaban tablets
  • reference apixaban tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
May 1, 2023

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and

Recruiting
  • Bioequivalence
  • Schizophrenia
  • Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023

Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
  • Tunis, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023

Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)

Not yet recruiting
  • Healthy
  • Daridorexant 10 mg
  • Daridorexant 25 mg
  • (no location specified)
Jun 1, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Healthy Subjects Trial in Amman (Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium

Completed
  • Bioequivalence
  • Healthy Subjects
  • Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
  • Nurofen® Forte Express, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
  • Amman, Jordan
    ACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022

Hyperlipidemias Trial in Qingdao (ezetimibe tablet, ezetimibe tablet(Ezetrol ®))

Completed
  • Hyperlipidemias
  • ezetimibe tablet
  • ezetimibe tablet(Ezetrol ®)
  • Qingdao, Shandong, China
    Clinical Research Center
Dec 27, 2022

Healthy Trial in Beijing (First Test Concor (Fasted), First Reference Concor (Fasted), First Test Concor (Fed))

Recruiting
  • Healthy
  • First Test Concor (Fasted)
  • +3 more
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University-Drug Cli
Jun 26, 2023